Teva Pharmaceuticals Competitors and Similar CompaniesClear all
WuXi AppTec's competitors and similar companies include Novartis, Pfizer and Roche.
 WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ||
Founding Date | Founding Date 2000 | Founding Date 1996 | Founding Date 1849 | Founding Date 1896 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | |
Employees | Employees 39,414 | Employees 75,883 | Employees 81,0008% decrease | Employees 103,249 |
Valuation ($) | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) |
Cost of goods | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) |
Gross profit | Gross profit ¥21.3b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) |
Net income | Net income ¥19.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income CHF13.8b (FY, 2025) |
Operating ⚠ | ||||
Patients | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients 22.8 m (FY, 2023) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 902.6m | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 7.8b |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company